28/10/2026
An exciting development in prostate cancer care has just been announced.
NICE has published draft recommendations supporting the use of five artificial intelligence technologies to help NHS radiologists detect prostate cancer on MRI scans. https://tinyurl.com/bddjbyn7
These AI systems could act as a second pair of eyes, helping doctors identify suspicious areas more accurately and consistently, potentially reducing delays and unnecessary investigations.
This is welcome news. But at Prost8 UK, we believe it raises an equally important question.
f technology is helping us identify prostate cancer with greater precision, shouldn't we also be treating it with greater precision?
For decades, the main radical treatment options have involved surgery to remove the prostate or radiotherapy to treat the whole gland.
Both remain essential, potentially lifesaving treatments. But not every man with localised prostate cancer necessarily needs treatment of the entire prostate.
For appropriately selected patients, focal therapies such as HIFU, cryotherapy and IRE (Nanoknife) can target areas of cancer while preserving more healthy tissue, potentially reducing the risk of life-changing side effects.
And for some men, active surveillance may be the most appropriate choice of all.
Artificial intelligence represents another exciting step towards more personalised prostate cancer care.
Let's make sure advances in diagnosis are matched by advances in treatment choice and access.
Because beating prostate cancer matters. But so does the life you live afterwards.
Every prostate cancer is different. Every treatment should be too.
Prost8 UK — Know Your Choices.
www.prost8.org.uk